cbdMD Corp - YCBD Quarterly Revenue Growth

Official company branding of cbdMD Corp (YCBD)

cbdMD, Inc. relies on efficient omnichannel delivery and a diversified supplier pool. Partnerships with athletes and the wellness industry are driving brand awareness growth. Meanwhile, a decline in consumer demand is creating a certain liquidity deficit, necessitating cost reductions. The quarterly revenue growth rate confirms these trends, with the current metric standing at 20.80, allowing for an assessment of the business development dynamics.

YCBD cbdMD Corp Quarterly Sales Growth (07/04/2022 - 11/20/2026)

Analytical breakdowns for cbdMD Corp (YCBD)

- stock price and consensus target price:
Fundamental company analysis:YCBD - cbdMD, Inc.
Flagship merchandise of cbdMD Inc.

This indicator captures the relative change in quarterly revenue, allowing for an assessment of business model stability and the identification of a dangerous weakening of the asset before a deep crisis occurs. By analyzing the quarterly revenue dynamics for cbdMD, Inc. (YCBD), an investor can track the company's loss of pricing power amid market saturation, making this metric a key signal of shrinking margins due to competitor dumping.

Direct competitors

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth LQDA (Liquidia Technologies)|Quarterly Revenue Growth Galapagos GLPG|ANI Pharmaceuticals Inc - Quarterly Revenue Growth|MNKD (MannKind Corp.) - Sales Growth QoQ|AMPH: Quarterly Revenue Growth|PCRX (Pacira BioSciences) - Revenue Growth QoQ|Revenue Growth QoQ ARS Pharmaceuticals Inc|Quarterly Sales Growth Theravance Biopharma, Inc. (TBPH)|Quarterly Sales Growth AQST (Aquestive Pharma)|SCPH - Quarterly Revenue Growth Rate|Quarterly Revenue Growth TECX (Tectonic Therapeutic, Inc.)|TNXP - Quarterly Sales Growth|China SXT Pharmaceuticals, Inc. - Quarterly Revenue Growth|EPRX - Quarterly Revenue Growth|BHST: Quarterly Revenue Growth|Quarterly Revenue Growth Rate eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Quarterly Revenue Growth|Sales Growth QoQ ENTX (Entera Bio)|Revenue Growth QoQ MindWalk (HYFT)|Quarterly Revenue Growth ABVC BioPharma, Inc. (ABVC)|Revenue Growth QoQ Cumberland Corp CPIX|QNTM - Quarterly Sales Growth|FGEN - Revenue Growth QoQ|TELO - Quarterly Revenue Growth|Rani Therapeutics Inc (RANI) - Revenue Growth QoQ|Sales Growth QoQ SNYR|Revenue Growth QoQ Rallybio Corp|Revenue Growth QoQ LEXX|Quarterly Revenue Growth PULM|PTHL: Revenue Dynamics QoQ|Quarterly Revenue Growth APM (Aptorum Group Ltd)|LYRA - Quarterly Sales Growth|Impact BioMedical Inc - Quarterly Revenue Growth|Revenue Dynamics QoQ TNFA|PainReform Ltd. (PRFX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Altamira Therapeutics (CYTO)|Revenue Growth QoQ Lipella Pharmaceuticals, Inc.|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)